What are BCMA -directed therapies and why do they raise infection risk? скачать в хорошем качестве

What are BCMA -directed therapies and why do they raise infection risk?

BCMA-directed therapies are an exciting breakthrough in multiple myeloma treatment, targeting a protein called B-cell maturation antigen to destroy cancer cells. But while these therapies—such as CAR T-cell therapy and bispecific antibodies—can be highly effective, they can also increase your risk of infection. In this video, we explain: What BCMA is and why it’s an important target in myeloma How BCMA-directed therapies work Why these treatments can weaken your immune system Steps you and your healthcare team can take to lower infection risk If you or a loved one is considering BCMA therapy, this video will help you better understand the benefits, risks, and questions to discuss with your doctor. #MultipleMyeloma #BCMA #CancerTreatment #CAR_T #BispecificAntibody #MyelomaTreatment #InfectionPrevention Watch the full course and our most up-to-date content here: https://linktr.ee/HealthTreeUniversity Create a free account to track your progress, bookmark lessons, and keep up-to-date on the latest advancements in treating cancer! Patients have the key to find cures for cancer. Learn more about HealthTree Cure Hub here: https://healthtree.org/curehub?utm_so... Educated and empowered patients have better outcomes. We've partnered with hundreds of medical experts and doctors to help you learn more about your disease.